Gene · 10313
Papers1,763
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,763
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterizing metals in particulate pollution in communities at the fenceline of heavy industry: combining mobile monitoring and size-resolved filter measurements. | Environ Sci Process Impacts | 2023 | 37584085 | PubTator, text mining | PubMed |
| Machine learning-based integration develops a neutrophil-derived signature for improving outcomes in hepatocellular carcinoma. | Front Immunol | 2023 | 37575244 | PubTator, text mining | PubMed |
| In Vitro Evaluation of Ag- and Sr-Doped Hydroxyapatite Coatings for Medical Applications. | Materials (Basel) | 2023 | 37570133 | PubTator, text mining | PubMed |
The use of antibiotic-loaded bone cement and systemic antibiotic prophylactic use in 2,971,357 primary total knee arthroplasties from 2010 to 2020: an international register-based observational study among countries in Africa, Europe, North America, and Oceania. | Acta Orthop | 2023 | 37565339 | PubTator, text mining | PubMed |
| The M2 proteins of bat influenza A viruses reveal atypical features compared to conventional M2 proteins. | J Virol | 2023 | 37540019 | PubTator, text mining | PubMed |
| Highly dispersed Co anchored on Ce-doped hydroxyapatite as a dual-functional catalyst for selective hydrogenolysis of 5-hydroxymethylfurfural. | Dalton Trans | 2023 | 37525869 | PubTator, text mining | PubMed |
| Multi-resolution Correlative Ultrastructural and Chemical Analysis of Carious Enamel by Scanning Microscopy and Tomographic Imaging. | ACS Appl Mater Interfaces | 2023 | 37524079 | PubTator, text mining | PubMed |
| Identification of novel gene signatures and immune cell infiltration in intervertebral disc degeneration using bioinformatics analysis. | Front Mol Biosci | 2023 | 37520321 | PubTator, text mining | PubMed |
| Evaluation of Remineralization Potential of Natural Substances on Artificially Induced Carious Lesions in Primary Teeth: An In Vitro Study. | Int J Clin Pediatr Dent | 2023 | 37519954 | PubTator, text mining | PubMed |
| Biocompatibility analysis and chemical characterization of Mn-doped hydroxyapatite. | J Mater Sci Mater Med | 2023 | 37515640 | PubTator, text mining | PubMed |
| Human Activity Prediction Based on Forecasted IMU Activity Signals by Sequence-to-Sequence Deep Neural Networks. | Sensors (Basel) | 2023 | 37514789 | PubTator, text mining | PubMed |
| The Reticulon-4 3-bp Deletion/Insertion Polymorphism Is Associated with Structural mRNA Changes and the Risk of Breast Cancer: A Population-Based Case-Control Study with Bioinformatics Analysis. | Life (Basel) | 2023 | 37511924 | PubTator, text mining | PubMed |
| Small-Molecule Loaded Biomimetic Biphasic Scaffold for Osteochondral Regeneration: An In Vitro and In Vivo Study. | Bioengineering (Basel) | 2023 | 37508874 | PubTator, text mining | PubMed |
| Engineering Antioxidant Surfaces for Titanium-Based Metallic Biomaterials. | J Funct Biomater | 2023 | 37504839 | PubTator, text mining | PubMed |
| Integrative proteomics highlight presynaptic alterations and c-Jun misactivation as convergent pathomechanisms in ALS. | Acta Neuropathol | 2023 | 37488208 | PubTator, text mining | PubMed |
| Printing tissue-engineered scaffolds made of polycaprolactone and nano-hydroxyapatite with mechanical properties appropriate for trabecular bone substitutes. | Biomed Eng Online | 2023 | 37474951 | PubTator, text mining | PubMed |
| Portal vein computed tomography imaging characteristics and their relationship with bleeding risk in patients with liver cirrhosis undergoing interventional therapy. | World J Clin Cases | 2023 | 37449217 | PubTator, text mining | PubMed |
| An Evaluation of the Mechanical Properties of a Hybrid Composite Containing Hydroxyapatite. | Materials (Basel) | 2023 | 37444862 | PubTator, text mining | PubMed |
| Electrochemical and Structural Characterization of Lanthanum-Doped Hydroxyapatite: A Promising Material for Sensing Applications. | Materials (Basel) | 2023 | 37444835 | PubTator, text mining | PubMed |
| Novel one-pot strategy for fabrication of a pH-Responsive bone-targeted drug self-frame delivery system for treatment of osteoporosis. | Mater Today Bio | 2023 | 37441135 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10313/papers?page=10